This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: 3St Research LLC, Albany Molecular Research, Inc., Takeda Pharmaceutical Company Limited. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 6 
2 out of 97 
1 out of 1,233 
Years Active: 2016-2021
Title: Innovator Spotlight: Fatoumata Camara - Pioneering Solutions in Opioid Abuse Prevention
Introduction:
Fatoumata Camara, a prolific inventor based in Albany, NY, is making significant strides in the field of pharmaceuticals with his groundbreaking work in opioid abuse prevention. With a total of three patents under his belt, Camara's innovative methods and compositions are revolutionizing the landscape of drug delivery systems and pharmaceutical compositions.
Latest Patents:
Camara's latest patents focus on the development of abuse-resistant opioid compounds, drug delivery systems, and pharmaceutical compositions designed to prevent opioid abuse. These patents encompass methods of delivering active ingredients to subjects while effectively deterring misuse and abuse. His cutting-edge research is poised to have a profound impact on enhancing patient safety and curbing the opioid crisis.
Career Highlights:
Throughout his career, Camara has been associated with esteemed companies such as Albany Molecular Research, Inc. and 3st Research LLC. His tenure at these organizations has been characterized by a relentless pursuit of innovative solutions and a commitment to driving positive change in the pharmaceutical industry. Camara's dedication to research and development has cemented his reputation as a trailblazer in the field.
Collaborations:
In his professional journey, Camara has collaborated closely with accomplished peers such as Matthew Surman and Kathryn Golden. Together, they have leveraged their diverse expertise to push the boundaries of pharmaceutical innovation and bring cutting-edge solutions to fruition. Camara's collaborative spirit and visionary approach have been instrumental in driving forward progress in opioid abuse prevention.
Conclusion:
Fatoumata Camara's contributions to the field of pharmaceuticals stand as a testament to his ingenuity and commitment to addressing pressing healthcare challenges. Through his pioneering patents and collaborative efforts, Camara continues to advance the frontier of opioid abuse prevention, offering hope for a safer and healthier future. His remarkable achievements underscore the transformative power of innovation in shaping a better tomorrow for individuals and communities alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile